Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

October 1, 2020

Conditions
Smoking Cessation
Interventions
OTHER

Nicotine E-Cigarette

OTHER

Non-Nicotine E-Cigarette

BEHAVIORAL

Counseling

Trial Locations (16)

T6G 2B7

Mazankowski Alberta Heart Institute, Edmonton

R2H 2A6

St. Boniface Hospital, Winnipeg

L8L 5G8

Allen Greenspoon Medicine Profesionnal Corporation, Hamilton

K7M 1W9

Baran Medicine Professional Corporation, Kingston

K1K 0T2

Institut de recherche de l'Hôpital Montfort, Ottawa

K1N 5N1

The Bridge Engagement Centre, Ottawa

K1Y 4E9

Ottawa Hospital, Ottawa

L4J 1W3

Canadian Centre for Clinical Trials, Thornhill

M4C 3E7

Michael Garron Hospital, Toronto

M5G 2C4

Toronto General Hospital, Toronto

H7M 3L9

Hôpital Cité-de-la-Santé, Laval

H2X 0A9

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

H3G 1A4

Montreal General Hospital, Montreal

H3T1E2

Jewish General Hospital, Montreal

G1V 4G5

Institut de cardiologie et de pneumologie de Québec (IUCPQ), Québec

J1J 3H5

Centre de recherche sur le vieillissement, Sherbrooke

All Listed Sponsors
collaborator

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

lead

McGill University

OTHER

NCT02417467 - Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial | Biotech Hunter | Biotech Hunter